Clinical-stage developer of small-molecule senolytics that selectively clear pathologic senescent cells driving age-related disease.
San Francisco biotech developing drugs that activate iNKT immune cells to clear senescent cells from the body.
The Audio Brief: everything you need to know about frontier tech in under 10 minutes a day.
30 sectors
One dashboard each, refreshed every day.
1,200+ companies
Funding, leadership, hiring, competitors.
Jobs board
Roles at companies LinkedIn never shows.
Frontier TV
A thousand-video wall from official channels.
Investors & exits
Who funds the frontier, and who bought what.
Frontline
The day's developments in every sector, scored.